Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Article Type
Article
Changed
Wed, 02/13/2019 - 15:55
Display Headline
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
Author(s)
Matthew T. Roe, MD
Shelly K. Sapp, MS
A. Michael Lincoff, MD
Article PDF
ccjm67_2-0131.pdf
Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(2)
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Hematology
Vascular
Page Number
131-140
Sections
Reviews
Author(s)
Matthew T. Roe, MD
Shelly K. Sapp, MS
A. Michael Lincoff, MD
Author(s)
Matthew T. Roe, MD
Shelly K. Sapp, MS
A. Michael Lincoff, MD
Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Article PDF
ccjm67_2-0131.pdf
Article PDF
ccjm67_2-0131.pdf
Issue
Cleveland Clinic Journal of Medicine - 67(2)
Issue
Cleveland Clinic Journal of Medicine - 67(2)
Page Number
131-140
Page Number
131-140
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Hematology
Vascular
Article Type
Article
Display Headline
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
Display Headline
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
Sections
Reviews
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Abciximab prevents ischemic complications during angioplasty

Article Type
Article
Changed
Mon, 04/01/2019 - 12:48
Display Headline
Abciximab prevents ischemic complications during angioplasty
The EPILOG Trial
Author(s)
Matthew T. Roe, MD
David J. Moliterno, MD
Article PDF
media_f52b277_ccjm65_5-0267.pdf
Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 65(5)
Publications
Cleveland Clinic Journal of Medicine
Page Number
267-272
Sections
Interpreting Key Trials
Author(s)
Matthew T. Roe, MD
David J. Moliterno, MD
Author(s)
Matthew T. Roe, MD
David J. Moliterno, MD
Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
media_f52b277_ccjm65_5-0267.pdf
Article PDF
media_f52b277_ccjm65_5-0267.pdf
The EPILOG Trial
The EPILOG Trial
Issue
Cleveland Clinic Journal of Medicine - 65(5)
Issue
Cleveland Clinic Journal of Medicine - 65(5)
Page Number
267-272
Page Number
267-272
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Abciximab prevents ischemic complications during angioplasty
Display Headline
Abciximab prevents ischemic complications during angioplasty
Sections
Interpreting Key Trials
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media
Subscribe to Matthew T. Roe, MD